Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Goldman Sachs Group (NY: GS )

602.78 +6.67 (+1.12%)
Official Closing Price Updated: 4:10 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Goldman Sachs Group

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Apple's AI Breakthroughs At WWDC 2024 Lead To Higher iPhone Sales Projections By Goldman Sachs
Goldman Sachs analysts optimistic about Apple's WWDC 24, citing strong AI features and OS updates driving product demand and revenue growth. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
How IZEA Worldwide (NASDAQ: IZEA) Is Leading The World Into The Creator Economy Era
How IZEA Worldwide (NASDAQ: IZEA) Is Leading The World Into The Creator Economy Era 
Via News Direct
Topics Economy
Exposures Economy
Goldman Sachs Gr Unusual Options Activity
Via Benzinga
The 3 Most Undervalued Utility Stocks to Buy in June 2024
Utility stocks are grossly undervalued. Names such as GWRS, ENB and AEP stand out due to their dynamic attributes and valuation metrics. 
Via InvestorPlace
3 Capital Markets Stocks to Buy Hand Over Fist in June
Diversify your portfolio with these cheap stocks today. 
Via The Motley Fool
$100 Invested In Goldman Sachs Gr 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Looking At Goldman Sachs Gr's Recent Unusual Options Activity
Via Benzinga
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
Goldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform. 
Via Benzinga
The 3 Best Dow Stocks to Buy in June 2024
Discover the three best Dow stocks to buy in June 2024. Invest in these top-performing companies with strong fundamentals. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Ready to Rally: Ride These 3 Stocks to Dow 50K
The Dow 30 has underperformed in 2024 on a relative basis to the S&P 500. Nonetheless, there are Dow stocks to buy. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades'
AbbVie Inc. has good dividend yield and attractive valuations, according to Jim Lebenthal of Cerity Partners. 
Via Benzinga
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
Dividend stocks have a record of stability and growth. Read here about three picks that are thriving and hiking dividends amid uncertainty. 
Via InvestorPlace
9 Financials Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Must-Buy Stocks if You Want to Retire Rich
Secure your retirement with these three must-buy stocks that offer solid growth and income potential over the coming decades. 
Via InvestorPlace
Topics Retirement
Exposures Pension
Dividend Aristocrats in Disguise: 3 Stocks With Royal Payout Potential
Explore three dividend aristocrats with strong payout potential, including Tractor Supply, Goldman Sachs, and Visa. 
Via InvestorPlace
Top Stock Picks For Week Of June 3, 2024
Shares of Goldman have outperformed the industry in the past six months. NVIDIA is benefiting from the strong growth of artificial intelligence (AI), high-performance, and accelerated computing. 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Data Centers Are Driving An Electricity Demand Surge From AI Platforms Like ChatGPT
Goldman Sachs says it’s projecting electricity demand to rise approximately 2.4% from 2022 to 2030, with data centers representing the largest growth segment at 0.9 percentage points—nearly a third of... 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia To Remain As A Benchmark For Computing Industry And Spur Demand, Say Analysts
Goldman Sachs analyst Toshiya Hari reiterated a Buy rating on the shares of Nvidia with a price target of $1,200. BofA Securities analyst Vivek Arya reiterated a Buy rating on the shares and raised the... 
Via Benzinga
Goldman Sachs, JPMorgan, And Wells Fargo Lead Bank Stocks Surge As Investors Bet On Soft Landing
Bank stocks have had a successful year with potential for more growth if economic stability is maintained. BofA predicts positive sector performance in US elections and potential regulatory changes. 
Via Benzinga
Goldman Sachs Has Potential For Significant Alpha Generation: Analyst
Goldman Sachs has a Buy rating and price target of $525; Shares declined by 0.9% to $452.47 at last check on Monday. 
Via Benzinga
Apple's WWDC 2024 Sneak Peek: Generative AI Strategy With Privacy Focus
Apple (NASDAQ:AAPL) to showcase AI strategy at WWDC 2024, Goldman Sachs sets bullish price target of $226.00, partnership with OpenAI and ramping up production of M2 Ultra processors. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Elon Musk-Jamie Dimon Ending Years-Long Feud? Report Says Billionaire's Attendance At JPMorgan's March Tech Conference Paved The Way For Truce
JPMorgan's refusal to underwrite leases of Tesla EVs in 2016 set Elon Musk and Jamie Dimon on a collision course. 
Via Benzinga
Best Buy To Stabilize Despite A Soft Q1, Analysts Say
Goldman Sachs analyst Kate McShane noted BBY reported better-than-expected Q1 results and provided guidance that still suggests a potential top-line recovery in the second half of the year. 
Via Benzinga
3 Stocks Riding High on Major Analyst Upgrades Last Week
Discover three stocks that have surged following significant analyst upgrades, capitalizing on a robust S&P 500 rally. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Dick's Sporting Goods Ramps Up Growth: Analysts Raise Targets Amid Strong Sales And Margin Gains
Wedbush maintains a Neutral rating on DKS, increasing the price target from $210 to $230. Goldman Sachs analyst Kate McShane said DKS reported solid first-quarter comp trends with balanced growth in... 
Via Benzinga
10 Financials Stocks Whale Activity In Today's Session
Via Benzinga
Weight Loss Drug Market To Rocket To $130B By 2030 With Eli Lilly, Novo Nordisk In Lead: Goldman Sachs
Goldman Sachs re-rated Eli Lilly and Novo Nordisk, citing potential for weight-loss drugs. Global sales expected to reach $130B by 2030. 
Via Benzinga
This Mark-Cuban-Backed Company Is Creating Waves In The Creator Economy
This Mark-Cuban-Backed Company Is Creating Waves In The Creator Economy 
Via News Direct
Topics Economy
Exposures Economy
Dick's Sporting Goods Raised Outlook After Strong Q1 Earnings, But Analyst Is Watching For Inventory Shrink Commentary
Goldman Sachs analyst Kate McShane reiterated a Buy rating on the shares of Dick's Sporting Goods. According to the analyst, the stock gained due to the earnings beat and higher 2024 guidance. 
Via Benzinga
Topics Earnings
Exposures Financial
Former Goldman Sachs Exec Beth Hammack Becomes Next Cleveland Fed President
Meet Beth Hammack, the incoming President & CEO of the Federal Reserve Bank of Cleveland. With 30+ years in finance, including roles at Goldman Sachs. 
Via Benzinga
Topics Economy
Exposures Interest Rates
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.